Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

The healthcare sector, including managed-care firms and drug powerhouses, is vastly underperforming the S&P 500 index. Here ...

Pharmacy giant CVS is facing several lawsuits over allegedly sending text messages to customers to avoid a Louisiana law against PBM business ...

Some patients reluctantly shifted to save money while others have appealed for coverage of Zepbound after having experienced ...

Pharmacists say insurance reimbursements fail to cover their costs. They say a new law isn’t enough to reverse the trend.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

The big health insurers Moody's rates now face shrinking profit margins at the Medicaid plans they manage for state ...

CVS Health Corporation CVS is scheduled to report second-quarter 2025 results on July 31, before the opening bell. In the ...

For CVS, Q2 earnings will be a critical inflection point. A miss could trigger a breakup or further decline, making the stock ...

CVS Health Corporation CVS is gaining investor attention as the stock trends higher ahead of its second-quarter earnings ...

Relator Sarah Behnke brought a qui tam action in February 2014 under the False Claims Act against CVS Caremark Corporation and related entities.